4JOP

CFTR Associated Ligand (CAL) PDZ bound to HPV16 E6 oncoprotein C-terminal peptide (TRRETQL)

4JOP の概要

• エントリーDOI: 10.2210/pdb4jop/pdb
• 関連するPDBエントリー: 4JOE 4JOF 4JOG 4JOH 4JOJ 4JOK 4JOR
• 分子名称: Golgi-associated PDZ and coiled-coil motif-containing protein, Protein E6 (3 entities in total)
• 機能のキーワード: pdz, cftr associated ligand, cal, fig, pist, human papillomavirus type 16, hpv16, e6 oncoprotein, peptide binding protein
• 由来する生物種: Homo sapiens (human); 詳細
• 細胞内の位置: Cytoplasm: Q9HD26; Host nucleus matrix: P03126
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 20517.47

構造登録者

Amacher, J.F.,Madden, D.R. (登録日: 2013-03-18, 公開日: 2014-01-22, 最終更新日: 2023-09-20)

主引用文献

Amacher, J.F.,Cushing, P.R.,Brooks, L.,Boisguerin, P.,Madden, D.R.
Stereochemical Preferences Modulate Affinity and Selectivity among Five PDZ Domains that Bind CFTR: Comparative Structural and Sequence Analyses.
Structure, 22:82-93, 2014

PubMed Abstract: PDZ domain interactions are involved in signaling and trafficking pathways that coordinate crucial cellular processes. Alignment-based PDZ binding motifs identify the few most favorable residues at certain positions along the peptide backbone. However, sequences that bind the CAL (CFTR-associated ligand) PDZ domain reveal only a degenerate motif that overpredicts the true number of high-affinity interactors. Here, we combine extended peptide-array motif analysis with biochemical techniques to show that non-motif "modulator" residues influence CAL binding. The crystallographic structures of 13 CAL:peptide complexes reveal defined, but accommodating stereochemical environments at non-motif positions, which are reflected in modulator preferences uncovered by multisequence substitutional arrays. These preferences facilitate the identification of high-affinity CAL binding sequences and differentially affect CAL and NHERF PDZ binding. As a result, they also help determine the specificity of a PDZ domain network that regulates the trafficking of CFTR at the apical membrane.

PubMed: 24210758
DOI: 10.1016/j.str.2013.09.019

実験手法

X-RAY DIFFRACTION (1.8 Å)